---
schema_version: "secwatch.filing_event.v1"
accession: "0001175680-26-000002"
form_type: "8-K"
ticker: "CYDY"
cik: "0001175680"
company_name: "CytoDyn Inc."
filed_at: "2026-04-30T23:59:59+00:00"
generated_at: "2026-05-15T00:33:39.540112+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# CytoDyn holds investor call for corporate and clinical update; no material results disclosed in filing

## Summary
- Company held investor call on April 30, 2026 at 1:00 p.m. PT to provide corporate and clinical update.
- Presentation materials furnished as Exhibit 99.1 titled 'Leronlimab – A Novel Therapeutic in CCR5+ Immuno-Oncology'.
- No specific financial or trial data included in the 8-K or exhibit; update is forward-looking without new quantitative details.

## SEC filing metadata
- accession: 0001175680-26-000002
- form_type: 8-K
- ticker: CYDY
- cik: 0001175680
- company_name: CytoDyn Inc.
- filed_at: 2026-04-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1175680/000117568026000002/0001175680-26-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1175680/000117568026000002/ck0001175680-20260430.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001175680-26-000002
- JSON: https://secwatch.observer/filing/0001175680-26-000002.json
- Plain text: https://secwatch.observer/filing/0001175680-26-000002.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.